|
Volumn 39, Issue 8, 2001, Pages 2850-2855
|
Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon α-2a
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
MACROGOL;
RECOMBINANT ALPHA2A INTERFERON;
VIRUS RNA;
ADULT;
ANTIVIRAL ACTIVITY;
ARTICLE;
ASSAY;
BLOOD SAMPLING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG RESPONSE;
FEMALE;
FOLLOW UP;
GENE AMPLIFICATION;
GENETIC TRANSCRIPTION;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
NONHUMAN;
PHASE 3 CLINICAL TRIAL;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RELAPSE;
RNA ANALYSIS;
TREATMENT OUTCOME;
ANTIVIRAL AGENTS;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON ALFA-2A;
NUCLEIC ACID AMPLIFICATION TECHNIQUES;
POLYETHYLENE GLYCOLS;
POLYMERASE CHAIN REACTION;
RNA, VIRAL;
SENSITIVITY AND SPECIFICITY;
TRANSCRIPTION, GENETIC;
TREATMENT OUTCOME;
HEPATITIS C VIRUS;
RNA VIRUSES;
|
EID: 0034879417
PISSN: 00951137
EISSN: None
Source Type: Journal
DOI: 10.1128/JCM.39.8.2850-2855.2001 Document Type: Article |
Times cited : (45)
|
References (25)
|